CDC37 and breast cancer: We have demonstrated that compounds 8c and 13g both bind to Hsp90 in the mid-micromolar range, interfere with the Hsp90–Cdc37 PPI, and exhibit in vitro anticancer activity against Ewing sarcoma, breast cancer, and leukemia cell lines.